GlassScriptPhysician profile
Cheryl A Haslinger
NPI 1609910868
$1,602.47
in general payments reported to CMS, 2019-2025
26 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $228 · 2023: $376 · 2024: $406 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.97 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $300.89 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $163.74 | 2021-2025 | |
| Amgen INC. | $160.04 | 2024-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $139.51 | 2023-2024 | Veozah |
| Biohaven Pharmaceuticals, INC. | $121.02 | 2021 | |
| Exact Sciences Corporation | $77.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $60.68 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $49.53 | 2023-2025 | Myfembree |
| Biogen, INC. | $46.30 | 2023-2024 | Zurzuvae |
| Gilead Sciences, INC. | $43.60 | 2022-2023 | |
| Medtronic, INC. | $42.94 | 2024-2025 | Truclear |
| Mylan Pharmaceuticals INC. | $40.59 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.08 | 2022-2024 | Gardasil 9, Gardasil |
| Evofem Biosciences, INC. | $36.77 | 2021-2023 | Phexxi |
| Agile Therapeutics, INC. | $33.86 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $33.57 | 2024-2025 | Zepbound |
| Therapeuticsmd, INC. | $31.74 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.21 | 2021-2023 | |
| Novo Nordisk INC | $30.96 | 2023-2024 | Wegovy |
| Hologic Sales and Service, LLC | $24.43 | 2024 | Aptima |
| Organon LLC | $20.73 | 2025 | Nexplanon |
| Pfizer INC. | $17.03 | 2025 | |
| Avion Pharmaceuticals | $14.79 | 2021 | |
| Smith+Nephew, INC. | $14.76 | 2022 | |
| Cepheid | $14.33 | 2023 | |
| Boston Scientific Corporation | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Haslinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.